Novasep is investing €4 million to expand cGMP capacity for clinical and commercial supply of APIs at its Chasse-sur-Rhône (FR) facility. The investment includes the installation of a new cGMP cryogenic production line, capable of operating at temperatures as low as -80°C. It is equipped with a 4m3 Hastelloy reactor, filter drier and clean room. The investment also includes an expansion of the cGMP pilot-plant capabilities with the addition of a new stream comprising a 400L Hastelloy react...